Short Interest in OneMedNet Corporation (NASDAQ:ONMD) Grows By 65.8%

OneMedNet Corporation (NASDAQ:ONMDGet Free Report) saw a significant growth in short interest in January. As of January 30th, there was short interest totaling 224,270 shares, a growth of 65.8% from the January 15th total of 135,229 shares. Approximately 0.8% of the company’s stock are short sold. Based on an average trading volume of 313,084 shares, the short-interest ratio is currently 0.7 days. Based on an average trading volume of 313,084 shares, the short-interest ratio is currently 0.7 days. Approximately 0.8% of the company’s stock are short sold.

OneMedNet Stock Performance

NASDAQ:ONMD opened at $0.65 on Friday. The company has a market capitalization of $32.95 million, a price-to-earnings ratio of -12.92 and a beta of 1.13. OneMedNet has a one year low of $0.30 and a one year high of $4.22. The stock has a 50-day simple moving average of $1.09 and a 200 day simple moving average of $1.26.

OneMedNet (NASDAQ:ONMDGet Free Report) last released its earnings results on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The business had revenue of $0.18 million during the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of OneMedNet in a research report on Friday, January 9th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Check Out Our Latest Stock Analysis on OneMedNet

Insider Activity

In related news, CEO Aaron Green sold 61,555 shares of the business’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $1.20, for a total value of $73,866.00. Following the transaction, the chief executive officer owned 1,804,103 shares in the company, valued at approximately $2,164,923.60. The trade was a 3.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 46.20% of the company’s stock.

Hedge Funds Weigh In On OneMedNet

Large investors have recently added to or reduced their stakes in the company. Correct Capital Wealth Management acquired a new position in OneMedNet in the third quarter worth $4,910,000. Exencial Wealth Advisors LLC lifted its position in shares of OneMedNet by 141.3% in the 3rd quarter. Exencial Wealth Advisors LLC now owns 3,599,460 shares of the company’s stock worth $3,923,000 after buying an additional 2,107,598 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of OneMedNet in the 4th quarter valued at about $119,000. State Street Corp grew its position in shares of OneMedNet by 41.5% during the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after buying an additional 34,200 shares during the last quarter. Finally, HRT Financial LP acquired a new stake in OneMedNet during the fourth quarter worth about $32,000. 0.95% of the stock is currently owned by institutional investors.

About OneMedNet

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Read More

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.